Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease

Clinical trial NCT06488209 · COMPLETED

Trial details

NCT number: NCT06488209
Sponsor: Almirall, S.A.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Autoimmune Disease

Start date: 2022-07-29
Primary completion: 2025-04-03
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.